Alan Menter. (2023). Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationAlan Menter. Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Adis, Springer Healthcare, 2023.
MLA (9th ed.) CitationAlan Menter. Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. Adis, Springer Healthcare, 2023.
Warning: These citations may not always be 100% accurate.